Olga Tura-Ceide

2.1k total citations
78 papers, 1.3k citations indexed

About

Olga Tura-Ceide is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Olga Tura-Ceide has authored 78 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pulmonary and Respiratory Medicine, 30 papers in Molecular Biology and 16 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Olga Tura-Ceide's work include Pulmonary Hypertension Research and Treatments (34 papers), Angiogenesis and VEGF in Cancer (16 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (8 papers). Olga Tura-Ceide is often cited by papers focused on Pulmonary Hypertension Research and Treatments (34 papers), Angiogenesis and VEGF in Cancer (16 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (8 papers). Olga Tura-Ceide collaborates with scholars based in Spain, United Kingdom and United States. Olga Tura-Ceide's co-authors include Joan Albert Barberà, Isabel Blanco, Víctor I. Peinado, Nicholas L. Mills, G R Barclay, David E. Newby, Kay Samuel, Paul H.A. Quax, Kondababu Kurakula and Marie‐José Goumans and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Olga Tura-Ceide

73 papers receiving 1.3k citations

Peers

Olga Tura-Ceide
Aiilyan K. Houng United States
Maria Fragiadaki United Kingdom
Cristina M. Alvira United States
Enyi Shi China
Noelyn Hung New Zealand
Olga Tura-Ceide
Citations per year, relative to Olga Tura-Ceide Olga Tura-Ceide (= 1×) peers Christian L. Lino Cardenas

Countries citing papers authored by Olga Tura-Ceide

Since Specialization
Citations

This map shows the geographic impact of Olga Tura-Ceide's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga Tura-Ceide with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga Tura-Ceide more than expected).

Fields of papers citing papers by Olga Tura-Ceide

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olga Tura-Ceide. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga Tura-Ceide. The network helps show where Olga Tura-Ceide may publish in the future.

Co-authorship network of co-authors of Olga Tura-Ceide

This figure shows the co-authorship network connecting the top 25 collaborators of Olga Tura-Ceide. A scholar is included among the top collaborators of Olga Tura-Ceide based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olga Tura-Ceide. Olga Tura-Ceide is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tura-Ceide, Olga, et al.. (2025). 3D modelling of pulmonary arterial stenosis and endothelial dysfunction in CTEPH. Lab on a Chip. 25(17). 4369–4384.
2.
Dhillon, Navneet K., et al.. (2025). Genetics of Long COVID: Exploring the Molecular Drivers of Persistent Pulmonary Vascular Disease Symptoms. Infectious Disease Reports. 17(1). 15–15. 1 indexed citations
3.
Shalaby, Sarah, Annabel Blasi, Yiliam Fundora, et al.. (2025). Isolation and immortalization of human portal vein endothelial cells: A novel research tool for studying splanchnic vasculature. JHEP Reports. 7(10). 101543–101543.
4.
Callejo, María, Daniel Morales‐Cano, Gema Mondéjar‐Parreño, et al.. (2024). Vitamin D receptor and its antiproliferative effect in human pulmonary arterial hypertension. Scientific Reports. 14(1). 27445–27445. 3 indexed citations
5.
Tura-Ceide, Olga, et al.. (2024). The Relevance of the Endothelium in Cardiopulmonary Disorders. International Journal of Molecular Sciences. 25(17). 9260–9260. 2 indexed citations
6.
Oliveira, Suellen D., Sharilyn Almodóvar, Ghazwan Butrous, et al.. (2024). Infection and pulmonary vascular diseases consortium: United against a global health challenge. Pulmonary Circulation. 14(4). e70003–e70003. 3 indexed citations
7.
Peinado, Víctor I., María Guitart, Isabel Blanco, et al.. (2023). Atrophy signaling pathways in respiratory and limb muscles of guinea pigs exposed to chronic cigarette smoke: role of soluble guanylate cyclase stimulation. American Journal of Physiology-Lung Cellular and Molecular Physiology. 324(5). L677–L693. 1 indexed citations
8.
Orriols, Ramón, et al.. (2023). Thrombosis Models: An Overview of Common In Vivo and In Vitro Models of Thrombosis. International Journal of Molecular Sciences. 24(3). 2569–2569. 13 indexed citations
9.
Samuel, Kay, et al.. (2023). Oxidative Stress and Antioxidant Therapy in Pulmonary Hypertension. Antioxidants. 12(5). 1006–1006. 17 indexed citations
10.
Youssef, L., F. Crovetto, Rui V. Simões, et al.. (2022). The Interplay between Pathophysiological Pathways in Early-Onset Severe Preeclampsia Unveiled by Metabolomics. Life. 12(1). 86–86. 17 indexed citations
11.
Orriols, Ramón, et al.. (2022). Post-COVID-19 patients show an increased endothelial progenitor cell production. Translational research. 243. 14–20. 21 indexed citations
12.
Blanco, Isabel, Robert Szulcek, Wim Timens, et al.. (2022). Metabolic profile in endothelial cells of chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension. Scientific Reports. 12(1). 2283–2283. 16 indexed citations
13.
Tura-Ceide, Olga, Constanza Morén, Mariona Guitart‐Mampel, et al.. (2021). Derivation and characterisation of endothelial cells from patients with chronic thromboembolic pulmonary hypertension. Scientific Reports. 11(1). 18797–18797. 23 indexed citations
14.
Blanco, Isabel, et al.. (2020). Updated Perspectives on Pulmonary Hypertension in COPD. SHILAP Revista de lepidopterología. 1 indexed citations
15.
Blanco, Isabel, et al.. (2020). Pulmonary Endothelial Dysfunction and Thrombotic Complications in Patients with COVID-19. American Journal of Respiratory Cell and Molecular Biology. 64(4). 407–415. 34 indexed citations
16.
Blanco, Isabel, Olga Tura-Ceide, Víctor I. Peinado, & Joan Albert Barberà. (2020). <p>Updated Perspectives on Pulmonary Hypertension in COPD</p>. International Journal of COPD. Volume 15. 1315–1324. 50 indexed citations
17.
Musri, Melina M., Núria Coll-Bonfill, Bradley A. Maron, et al.. (2018). MicroRNA Dysregulation in Pulmonary Arteries from Chronic Obstructive Pulmonary Disease. Relationships with Vascular Remodeling. American Journal of Respiratory Cell and Molecular Biology. 59(4). 490–499. 38 indexed citations
18.
Padfield, Gareth J., et al.. (2012). Percutaneous coronary intervention mobilizes vascular resident CD34+CD45-cells directly through mechanical vascular injury. European Heart Journal. 33. 400–400. 1 indexed citations
19.
Tura-Ceide, Olga, Jeffrey D. Crawford, G R Barclay, et al.. (2010). Granulocyte colony‐stimulating factor (G‐CSF) depresses angiogenesis in vivo and in vitro: implications for sourcing cells for vascular regeneration therapy. Journal of Thrombosis and Haemostasis. 8(7). 1614–1623. 23 indexed citations
20.
Gallagher, Ronald, et al.. (2010). Analysis of Wnt pathway genes duringex vivoexpansion and neutrophil differentiation of umbilical cord-blood derived CD34+cells. Vox Sanguinis. 98(3p1). e290–e294. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026